Attached files

file filename
8-K - 160203 ASNB FORM 8K - EKIMAS Corpasnb160204_8k.htm






Exhibit 16.1




February 3, 2016




Securities and Exchange Commission

100 F Street, N.E.

Washington, D.C. 20549




Ladies and Gentlemen:


We have read Item 4.01 of Form 8-K dated February 3, 2016 of AdvanSource Biomaterials Corporation and are in agreement with the statements contained in the first sentence with regards to the dismissal of Liggett & Webb, P.A. of the first paragraph, and the second, third and fourth paragraphs therein in their entirety.  We have no basis to agree or disagree with other statements of the Registrant contained therein.




/s/ Liggett & Webb, P.A.

Certified Public Accountants